The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response
NCT06050395 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-03-31
Summary
The purpose of the study is to evaluate the feasibility and acceptability of a remote nutrition coaching and monitoring intervention during the 12-weeks of active chemotherapy for borderline resectable and locally advanced pancreatic cancer participants.
Conditions
Interventions
- BEHAVIORAL
-
Quality fo Life Questionnaire (FHSI)
Participants will take a survey at baseline and visit 2 (weeks 6-8), and visit 3 (week 10-14). The Functional Assessment of Cancer Therapy Hepatobiliary Cancer Symptom Index-8 (FHSI) questionnaire uses a 5-point Likert-type scale, 0=not at all and 4=Very much. A lower total score indicates better quality of life.
- BEHAVIORAL
-
Vioscreen Food Frequency Questionnaire (FFQ)
Participants will receive a web-based link and information to complete VioScreen, a web-based food frequency questionnaire, which allows participants to choose the average frequency of consumption of food items over a given time frame (1 month, 3 month, 1 year, etc.) on a Likert scale with choices ranging by individual questions. Total energy and nutrient intake is estimated by summing intakes from each food based on the selected portion size, reported frequency of consumption, and nutrient content of each food item. Anti-inflammatory and pro-inflammatory dietary patterns are calculated using the energy-adjusted dietary inflammatory index (DII) score to represent the inflammatory potential of an individual's overall diet, using data from FFQ responses. Higher DII scores represent more pro-inflammatory diets while lower (i.e., more negative) DII scores represent more anti-inflammatory diet.
- BEHAVIORAL
-
Educational Handouts
Participants will receive educational handouts on diet.
- BEHAVIORAL
-
NutritionCoaching
Participants will receive bi-weekly nutrition coaching on anti-inflammatory dietary patterns and foods.
- BEHAVIORAL
-
Follow-Up Survey
Participants will complete a custom exit/follow up survey regarding relevance, acceptability, intervention length and timing, an barriers/facilitators. This survey contains 38 questions scored from 1 -Strongly agree to 5-Strongly disagree. A lower score indicates patient satisfaction with the program and the skills and knowledge gained in the program.
- BEHAVIORAL
-
Functional Assessment of Anorexia/Cachexia Treatment (FAACT) Questionnaire
The FAACT questionnaire uses a 5 point Likert-type scale, 0=Not at all, 4=Very much. A higher score indicates better appetite and quality of life.
- BEHAVIORAL
-
Patient Reported Outcomes Measure- Cognitive Function (PROMIS-Cog) Questionnaire
Participants will complete the PROMIS-Cog form which measures self-reported cognitive deficits. The questionnaire uses a 5 point Likert-type scale, 1=Very often and 5=Never. A higher score indicates higher cognitive function.
Sponsors & Collaborators
-
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Principal Investigators
-
Sylvia Crowder, PhD · Moffitt Cancer Center
-
Pamela Hodul, MD · Moffitt Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-12
- Primary Completion
- 2025-01-17
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer
NCT02921646 ·Status: TERMINATED ·Phase: NA
-
Patient Reported Outcomes Registry in Patient With Cancer Cachexia
NCT02983500 ·Status: COMPLETED
-
The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
NCT01989000 ·Status: COMPLETED ·Phase: NA
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
NCT02342847 ·Status: COMPLETED
-
Parenteral Nutrition Support for Patients With Pancreatic Cancer
NCT00919659 ·Status: COMPLETED ·Phase: PHASE2
-
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
NCT03187951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
NCT01959672 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
NCT02318095 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
NCT02349867 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
NCT02243358 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
NCT04466189 ·Status: ENROLLING_BY_INVITATION
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
NCT04669197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A First-in-Human Study of FID-022 in Solid Tumor Patients
NCT07249775 ·Status: RECRUITING
-
Role of Perfusion CT in Pancreatic Cancer
NCT01703650 ·Status: UNKNOWN
-
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)
NCT06149546 ·Status: RECRUITING ·Phase: NA
-
Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients
NCT02400398 ·Status: COMPLETED
-
Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX
NCT03798769 ·Status: COMPLETED ·Phase: NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
NCT06001268 ·Status: RECRUITING ·Phase: NA
-
Gene Expression in Pancreatic Cancer
NCT03531125 ·Status: TERMINATED
-
Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
NCT01995240 ·Status: COMPLETED ·Phase: NA
-
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
NCT05325281 ·Status: TERMINATED ·Phase: PHASE1
-
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT00805688 ·Status: COMPLETED